Liver cancer screening for people at high risk
Part of Cancer, Digestive system, Infections clinical trials.
This study tests a new way to find liver cancer early in people who are at higher risk, using regular ultrasound and blood tests. If you qualify, you'll get close monitoring to catch any problems sooner, which may improve treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have liver cirrhosis, chronic hepatitis B with higher risk of liver cancer, advanced liver fibrosis (stage 3 or higher), or fatty liver disease with certain risk factors.
- You have never been diagnosed with liver cancer before.
- You are not currently diagnosed with liver cancer or other liver tumors.
- You are able to attend regular check-ups and give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This trial is testing a new way to screen for liver cancer in people with cirrhosis or chronic hepatitis B. It aims to find cancer earlier so it can be treated more effectively.
This trial tests a new blood test to help detect liver cancer (HCC) or confirm it’s not present in people with cirrhosis who are being monitored. It may help improve how doctors screen for liver cancer and decide who needs further imaging or treatment.
This study tests whether adding a simple blood test (GAAD score) to a routine liver ultrasound can find early-stage liver cancer sooner in people with chronic liver conditions. It aims to improve detection in Asian populations at risk.
This study looks at how well doctors can detect small, early liver cancer and then follow how it changes over time. It may help your care team choose the best next steps based on earlier, clearer detection.
This trial tests a tool to help doctors and patients decide when to screen for liver cancer. It is for people with cirrhosis who have not had imaging in the last 6 months.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.